Prostate Cancer Companies in BioPortfolio's Corporate Database
Prostate Cancer company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Prostate Cancer companies that have been added to our BioPortfolio's life-science corporate directory.
Search For More Prostate Cancer Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Prostate Cancer Companies.
More Information about Prostate Cancer on BioPortfolio
We have published hundreds of Prostate Cancer news stories on BioPortfolio along with dozens of Prostate Cancer Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Prostate Cancer for you to read.
Showing "prostate" Companies 1 to 25 of 135
Tokai Pharmaceuticals is a U.S. biopharmaceutical company focused on developing new treatments for prostate cancer. The companyâs lead drug candidate, TOK-001, is the first investigational new drug that can decrease overall androgen receptor levels in prostate tumors and in which three distinct mechanisms of action are combined in one oncotherapeutic....
Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates de...
Molecular Templates Inc. is creating an entirely new generation of potent anti-cancer agents based on proprietary applied proteomics technologies.The novel therapeutic agents in development by MTI are aimed particularly at melanoma, prostate and other metastatic cancers. Such agents are derived from the sophisticated mutation and selection of Shiga-like toxin (SLT) variants using recombinant DNA...
Mitomics is the world leader in the research and development of mitochondrial DNA (mtDNA)-based biomarkers â a new and innovative approach to the detection of cancer and other disease states. Leveraging its unparalleled insights into the role of mitochondria in cancer, the company is developing an extensive and proprietary portfolio of molecular tests...
Dan Sperling, MD, D.A.B.R., is the Medical Director at the New Jersey Institute of Radiology, in Carlstadt, N.J. Certified by the American Board of Radiology and licensed in New York and New Jersey, Dr. Sperling completed a fellowship in Cardiothoracic/Body Imaging with Interventions at the Albert Einstein College of Medicine at Montefiore Medical Center i...
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The Companyâs RezÅ«m System delivers vapor directly to the prostate to reduce the tissue volume that causes urinary obstruction in a simple, office-based procedure designed to take only minutes, with minimal discomfort, and resulting in rapid and significant...
Tokai Pharmaceuticals is a U.S. biopharmaceutical company focused on developing new treatments for prostate cancer. The companyâs lead drug candidate, galeterone (TOK-001), is the first investigational new drug that can decrease overall androgen receptor levels in prostate tumors and in which three distinct mechanisms of action are combined in one onc...
Coalition to Cure Prostate Cancer
The Coalition to Cure Prostate Cancer is a philanthropic organization that funds and accelerates advanced prostate cancer research in Canada. Beginning in 2011, the Coalition has identified unique strategies to invest in the most promising research programs that generate life-saving results. By channeling resources to Canadaâs top scientific minds, red...
Predictive Biosciences develops novel molecular diagnostic cancer assays and provides molecular pathology services for urology-based practices. Leveraging a portfolio of patented biomarkers and clinical approaches, the company has built a unique portfolio of assays for cancer management, first targeted at bladder and prostate cancer. The company is backed...
CDH Proton Center, A ProCure Center, Warrenville, Ill., is one of a handful of facilities in the country that offer proton therapy, an advanced form of radiation to treat cancer. The four-room, 60,000 sq. ft. Center, opened Oct. 19, 2010, is the first for Illinois and has the capacity to treat up to 1,500 patients a year. The precision of proton therapy sp...
Neogenix Oncology is a development stage biotechnology company focused on developing and commercializing therapeutic and diagnostic products for the early detection and treatment of pancreatic, colorectal, lung, cervical, ovarian, prostate, and other cancers. The companyâs portfolio includes monoclonal antibodies that are designed to be specific to ca...
Predictive Biosciences is a fully-integrated developer of novel molecular diagnostic cancer assays, and a subspecialty, urology-focused provider of anatomic pathology laboratory products and services. Leveraging a portfolio of patented biomarkers and clinical approaches, the company is building a unique portfolio of assays for cancer management, first targ...
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc., of Tarrytown, NY, is a biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Principal programs are directed toward supportive care, oncology and virology. Progeni...
Radiation Therapy Services, Inc.
Radiation Therapy Services, Inc. is a leading developer and operator of radiation therapy centers. These centers, which are freestanding and hospital based, provide a full spectrum of radiation therapy services to cancer patients, including conventional external beam radiation treatments as well as advanced services such as prostate seed implants (brachyth...
IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of the Cesium-131 brachytherapy seed, used to treat prostate and other cancers. The Cesium-131 seed offers a significantly shorter half-life than the two other isotopes commonly used for brachytherapy, which results in a substantially faster delivery of therapeutic radiation,...
MabCure is a biotechnology company whose vision is to change the perception of cancer as being a largely incurable disease. MabCure owns proprietary technology for the creation of unique and highly specific monoclonal antibodies (MAbs) which will be developed as diagnostic tools, imaging agents and drugs to treat lethal cancers. MabCureâs initial goal...
Teva Pharmaceutical Industries Ltd. & OncoGenex Pharmaceuticals, Inc.
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the le...
Northwest Biotherapeutics (NWBT) is a biotechnology company focused on the clinical development of autologous immunotherapy products for cancer. Our technology platform, DCVax®, uses a patient’s own dendritic cells, the starter engine of the immune system, which are loaded with tumor proteins or antigens. Injection of these cells back into the patient initiates a potent immune response against...
Mick Radio-Nuclear Instruments, Inc.
Mick Radio-Nuclear Instruments, Inc., known internationally for its 30+ years of service to the Radiation Therapy community, provides high-quality and state-of-the-art instrumentation and accessories encompassing the entire spectrum of Radiation Therapy. Products are manufactured in an ISO Certified facility in accordance with the requirements of ISO 13485:2003. All Mick products are FDA 510 (k) a...
Monash Institute of Medical Research (MIMR) is the premier medical research entity for Monash University and Southern Health, uniting the talents of researchers, clinicians and biotechnology experts from a range of biomedical fields. Its vision is to enhance human health and quality of life by major research innovation and discovery in biology, medicine, biotechnology and health services research....
We are a biopharmaceutical company focused on in-licensing, developing and commercializing novel therapies for the treatment of cancer. We currently have two clinical-stage oncology product candidates. Our lead product candidate, Asentar™ (DN-101), is in a Phase 3 clinical trial for the treatment of androgen-independent prostate cancer, or AIPC, also known as hormone-refractory prostate cancer....
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative oncology products to impact the lives of people with cancer. We are currently focusing our development efforts on picoplatin, a new generation platinum therapy that provides a differentiated spectrum of activity and an improved safety profile. An intravenous chem...
Nucletron is a radiotherapy company that specializes in the development, manufacture, sales, service and support of the world's most innovative products for cancer treatment. As a company, our guiding principle is the customer's demand for quality, safety and reliability. We continuously invest in innovative research and development. This approach has made it possible to successfully treat cancers...
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is a biopharmaceutical company specializing in the research and development of therapeutics and diagnostics for the aging population.Nymox has an extensive pipeline of products under development, including therapeutics for enlarged prostate (BPH), a common affliction of males over the age of 50, and for Alzheimer's disease, the most common cause of de...
Onconome is dedicated to the discovery, development and commercialization of innovative biomarkers for the early and accurate detection of prostate, colon, bladder and other forms of cancer, including lung, breast, liver, pancreatic and stomach. Early detection is the key to successful treatment. Our serum tests for early detection of prostate and colon cancer and our urine test for bladder cancer...
